NCT04808739View on ClinicalTrials.gov

Adalimumab Biosimilar in Clinical Practice

CompletedOBSERVATIONAL
Enrollment

604

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Psoriasis
Interventions
BIOLOGICAL

Adalimumab

Analysis of survival of adalimumab biosimilar in clinical practice

Trial Locations (1)

08041

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT04808739 - Adalimumab Biosimilar in Clinical Practice | Biotech Hunter | Biotech Hunter